You have 9 free searches left this month | to do more

bicalutamide

Bicalutamide is a drug used to treat Prostate Cancer, Prostate Adenocarcinoma, Prostatic Neoplasms, and other conditions. Bicalutamide is being actively studied in 37 studies and prior, has been studied in 57.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)University of Michigan Comprehensive Cancer CenterMary-Ellen Taplin, MD
AstraZenecaDecatur Memorial HospitalAjjai Alva, MD
Radiation Therapy Oncology GroupWest Michigan Cancer CenterAmy Tiersten
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer
Recruiting
  • Prostate Adenocarcinoma
  • bicalutamide
  • Stereotactic body radiation therapy
  • Bethesda, Maryland
    National Cancer Institute
2021-10-01
Oct 1, 2021
I
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
Recruiting
  • Breast Cancer
  • Metastasis
  • New York, New York
  • +2 more
2021-10-14
Oct 14, 2021
P
Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients
Recruiting
  • Breast Neoplasm Female
  • +3 more
  • Portland, Oregon
    Providence Oncology & Hematology Care Clinic - Eastside
2022-01-31
Jan 31, 2022
M
Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)
Active, not recruiting
  • Metastatic Breast Cancer (MBC)
  • Basking Ridge, New Jersey
  • +4 more
2021-10-29
Oct 29, 2021
M
Bicalutamide in Treating Patients With Metastatic Breast Cancer - 2021
Completed
  • Breast Cancer
  • bicalutamide
  • +2 more
  • San Francisco, California
  • +7 more
2021-06-25
Jun 25, 2021
K
Ribociclib and Bicalutamide in AR+ TNBC
Active, not recruiting
  • Triple Negative Breast Cancer
  • Chicago, Illinois
  • +4 more
2022-02-16
Feb 16, 2022
B
LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer
Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +2 more
  • Birmingham, Alabama
  • +3 more
2021-03-02
Mar 2, 2021
M
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • Bicalutamide
  • +3 more
  • (no location specified)
2022-01-05
Jan 5, 2022
U
FDHT PET and Bicalutamide in Metastatic Breast Cancer - 2019
Completed
  • Breast Cancer
  • Bicalutamide
  • FDHT PET
  • Groningen, Netherlands
    University Medical Center Groningen
2019-11-26
Nov 26, 2019
S
Exploratory Study of Molecular Profile-Associated Evidence Guided Precision Therapy for Salivary Gland Cancer（MAPS）
Recruiting
  • Salivary Gland Neoplasms
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Ton
2021-10-08
Oct 8, 2021
U
Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer
Active, not recruiting
Has Results
  • Prostate Cancer
  • Bicalutamide
  • +3 more
  • Chicago, Illinois
    University of Chicago
2021-09-30
Sep 30, 2021
S
A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
Active, not recruiting
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +1 more
2022-03-29
Mar 29, 2022
U
Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
2021-12-27
Dec 27, 2021
M
Micro RNAs to Predict Response to Androgen Deprivation Therapy
Active, not recruiting
  • Prostate Cancer
  • Bicalutamide
  • +7 more
  • Milwaukee, Wisconsin
    Froedtert Hospital
2021-02-17
Feb 17, 2021
S
A Study of Definitive Therapy to Treat Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +2 more
2021-10-11
Oct 11, 2021
D
INTREPId (INTermediate Risk Erection PreservatIon Trial)
Recruiting
  • Prostate Cancer
  • Bicalutamide
  • +3 more
  • Stamford, Connecticut
  • +4 more
2022-03-28
Mar 28, 2022
R
Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer - 2004
Completed
  • Prostate Cancer
  • bicalutamide
  • +4 more
  • Toronto, Ontario, Canada
    Toronto Sunnybrook Regional Cancer Centre
2020-10-21
Oct 21, 2020
S
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
Active, not recruiting
  • Prostate Adenocarcinoma
  • +4 more
  • Internal Radiation Therapy
  • +7 more
  • Stanford, California
    Stanford University, School of Medicine
2022-02-01
Feb 1, 2022
C
Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
Active, not recruiting
Has Results
  • PSA Level Greater Than Two
  • Stage IV Prostate Adenocarcinoma AJCC v7
  • Bicalutamide
  • +4 more
  • Duarte, California
  • +1 more
2022-04-04
Apr 4, 2022
T
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
Recruiting
  • High-risk Prostate Cancer
  • Prostate Cancer
  • Houston, Texas
    Houston Methodist Hospital
2021-04-05
Apr 5, 2021
F
Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)
Active, not recruiting
  • Prostate Cancer
  • Bicalutamide
  • +5 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
2020-07-05
Jul 5, 2020
M
Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer
Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-17
Nov 17, 2021
D
Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)
Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
2022-03-07
Mar 7, 2022
C
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
2021-08-10
Aug 10, 2021
M
Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Withdrawn
  • Stage I Prostate Adenocarcinoma
  • Stage II Prostate Adenocarcinoma
  • Bicalutamide
  • +3 more
  • (no location specified)
2019-01-17
Jan 17, 2019